Vimseltinib Dihydrate

Details

Stereochemistry	ACHIRAL
Molecular Formula	C23H25N7O2.2H2O
Molecular Weight	467.5209
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

O.O.CC(C)NC1=NC=C(C(=O)N1C)C2=NC(C)=C(OC3=CC=NC(=C3)C4=CN(C)N=C4)C=C2

InChI

InChIKey=HGTIRPPJQQAIKG-UHFFFAOYSA-N

InChI=1S/C23H25N7O2.2H2O/c1-14(2)27-23-25-12-18(22(31)30(23)5)19-6-7-21(15(3)28-19)32-17-8-9-24-20(10-17)16-11-26-29(4)13-16;;/h6-14H,1-5H3,(H,25,27);2*1H2

HIDE SMILES / InChI

Approval Year

Name

Type

Language

Vimseltinib Dihydrate

Official Name

English

ROMVIMZA

Preferred Name

English

4(3H)-Pyrimidinone, 3-methyl-2-[(1-methylethyl)amino]-5-[6-methyl-5-[[2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy]-2-pyridinyl]-. hydrate (1:2)

Systematic Name

English

3-Methyl-2-[(1-methylethyl)amino]-5-[6-methyl-5-[[2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy]-2-pyridinyl]-4(3H)-pyrimidinone dihydrate

Systematic Name

English

Code System Code Type Description

FDA UNII

89JWT5T56Y

Created by admin on Wed Apr 02 19:17:56 GMT 2025 , Edited by admin on Wed Apr 02 19:17:56 GMT 2025

PRIMARY

ACTIVE MOIETY


					PX9FTM69BF

VIMSELTINIB

SUBSTANCE RECORD


					89JWT5T56Y

Vimseltinib Dihydrate